Tyers Asset Management’s AbbVie ABBV Stock Holding History

Tyers Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$6.13M	Buy	80,928 +29,728	+58%	+$2.04M	0.2%	97
2019 Q2	$3.72M	Sell	51,200 -2,048	-4%	-$161K	0.13%	153
2019 Q1	$4.29M	Sell	53,248 -43,744	-45%	-$3.58M	0.15%	132
2018 Q4	$8.94M	Sell	96,992 -35,264	-27%	-$3.1M	0.36%	60
2018 Q3	$12.5M	Buy	132,256 +25,856	+24%	+$2.45M	0.41%	58
2018 Q2	$9.86M	Buy	106,400 +7,536	+8%	+$736K	0.34%	69
2018 Q1	$9.36M	Buy	98,864 +49,504	+100%	+$5.44M	0.33%	73
2017 Q4	$4.77M	Buy	49,360 +37,520	+317%	+$3.54M	0.17%	123
2017 Q3	$1.05M	Sell	11,840 -1,808	-13%	-$138K	0.04%	268
2017 Q2	$990K	Sell	13,648 -240	-2%	-$16.1K	0.04%	281
2017 Q1	$905K	Sell	13,888 -3,344	-19%	-$210K	0.03%	293
2016 Q4	$1.08M	Buy	+17,232	New	+$1.05M	0.05%	248

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Tyers Asset Management's ABBV Position: Q3 2019 in Review

Tyers Asset Management increased its AbbVie (ABBV) stake by 58% in Q3 2019, buying an estimated $2.04M and bringing the position to 80,928 shares worth $6.13M. The position accounts for 0.2% of the portfolio, ranked #97.

Tyers Asset Management first reported a position in ABBV in Q4 2016 and has held it in 12 quarters since. The position peaked at $12.5M in Q3 2018. 2,003 funds tracked by Wall St. Rank hold ABBV as of Q3 2019.

Tyers Asset Management held 80,928 shares of AbbVie worth $6.13M as of Q3 2019.
Tyers Asset Management bought 29,728 AbbVie shares in Q3 2019, an estimated $2.04M.
AbbVie made up 0.2% of Tyers Asset Management's portfolio in Q3 2019, its #97 holding.
Tyers Asset Management first reported a position in AbbVie in Q4 2016 and has held it in 12 quarters since.
Tyers Asset Management's AbbVie position peaked at $12.5M in Q3 2018.
2,003 funds tracked by Wall St. Rank held AbbVie as of Q3 2019.

Based on Tyers Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.